TY - JOUR
T1 - Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis
AU - Yamakawa, Makoto
AU - Mukaino, Akihiro
AU - Kimura, Akio
AU - Nagasako, Yuki
AU - Kitazaki, Yuki
AU - Maeda, Yasushi
AU - Higuchi, Osamu
AU - Takamatsu, Koutaro
AU - Watari, Mari
AU - Yoshikura, Nobuaki
AU - Ikawa, Masamichi
AU - Sugimoto, Izumi
AU - Sakurai, Yasuhisa
AU - Matsuo, Hidenori
AU - Ando, Yukio
AU - Shimohata, Takayoshi
AU - Nakane, Shunya
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/12/15
Y1 - 2020/12/15
N2 - Since autonomic dysfunction is closely associated with autoimmune encephalitis (AE), the objective of this study was to determine the autonomic symptoms and the prevalence of anti-α3 subunit of the ganglionic-type nicotinic acetylcholine receptor (gAChRα3) antibodies in the patients with AE. We reviewed the clinical features of 19 AE patients, and specifically analyzed sera for anti-gAChRα3 antibodies using the luciferase immunoprecipitation system (LIPS) assay. Cardiovascular autonomic symptoms were found to be common in patients with AE, and hypersalivation was seen only in patients with NMDAR encephalitis. LIPS detected anti-gAChRα3 antibodies in the sera from patients with AE (5/29, 26%). This study is the first to demonstrate that clinical characteristics including autonomic symptoms of AE patients with seropositivity for gAChR autoantibodies. It will be important to verify the role of gAChR antibodies in autonomic dysfunction and brain symptoms to clarify the pathogenesis of AE.
AB - Since autonomic dysfunction is closely associated with autoimmune encephalitis (AE), the objective of this study was to determine the autonomic symptoms and the prevalence of anti-α3 subunit of the ganglionic-type nicotinic acetylcholine receptor (gAChRα3) antibodies in the patients with AE. We reviewed the clinical features of 19 AE patients, and specifically analyzed sera for anti-gAChRα3 antibodies using the luciferase immunoprecipitation system (LIPS) assay. Cardiovascular autonomic symptoms were found to be common in patients with AE, and hypersalivation was seen only in patients with NMDAR encephalitis. LIPS detected anti-gAChRα3 antibodies in the sera from patients with AE (5/29, 26%). This study is the first to demonstrate that clinical characteristics including autonomic symptoms of AE patients with seropositivity for gAChR autoantibodies. It will be important to verify the role of gAChR antibodies in autonomic dysfunction and brain symptoms to clarify the pathogenesis of AE.
KW - Autoantibody
KW - Autoimmune encephalitis
KW - Autonomic dysfunction
KW - Ganglionic acetylcholine receptor
KW - NMDAR encephalitis
UR - http://www.scopus.com/inward/record.url?scp=85091583782&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2020.577399
DO - 10.1016/j.jneuroim.2020.577399
M3 - 学術論文
C2 - 32980672
AN - SCOPUS:85091583782
SN - 0165-5728
VL - 349
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
M1 - 577399
ER -